Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page
- Check7 days agoChange DetectedAdded a new revision entry for v3.5.2 and removed the earlier revision v3.5.0 in the record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History, updating the list of study record revisions.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history shows that revision v3.4.3 was added and revision v3.4.2 was removed from the version list.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding/operating status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check78 days agoChange DetectedAdded a government funding notice and updated the history to v3.4.1, while removing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check85 days agoChange DetectedNew UI elements include a glossary toggle, color-coded green additions and red deletions, and an updated revision label to enhance the history display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.